RDEA Insider Trading Activity and SEC Form 4 Filings
RDEA insider trading summary
No open-market insider purchases or sales of Ardea Biosciences, Inc./DE (RDEA) have been reported on SEC Form 4 in the past 12 months.
Latest RDEA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 19, 2012 | Kimberly Manhard | SVP, Regulatory & Dev Ops | Sell | $410K (12,829 @ $31.96) |
| Jun 11, 2012 | John W Beck | SVP, Finance & Operations, CFO | Sell | $897K (28,048 @ $31.97) |
| May 29, 2012 | Kimberly Manhard | SVP, Regulatory & Dev Ops | Sell | $159K (5,000 @ $31.89) |
| Apr 30, 2012 | Kimberly Manhard | SVP, Regulatory & Dev Ops | Sell | $159K (5,000 @ $31.82) |
| Apr 25, 2012 | Henry J Fuchs | Director | Sell | $316K (10,000 @ $31.64) |
| Mar 28, 2012 | Kimberly Manhard | SVP, Regulatory & Dev Ops | Sell | $113K (5,000 @ $22.65) |
| Feb 28, 2012 | Kimberly Manhard | SVP, Regulatory & Dev Ops | Sell | $105K (5,000 @ $20.99) |
| Feb 1, 2012 | Julian Baker | Director | Buy | $14.9M (876,828 @ $17.00) |
| Feb 1, 2012 | Julian Baker | Director | Buy | $394K (23,172 @ $17.00) |
| Feb 1, 2012 | 14159 capital (GP), LLC | Director | Buy | $394K (23,172 @ $17.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.